Pharmafile Logo

Horizant

Sir Philip Hampton set to be new GSK chair

RBS chairman to replace Sir Christopher Gent

- PMLiVE

GSK fined $487m as Chinese probe concludes

Five former executives receive jail sentences

- PMLiVE

NICE fast-tracks GSK’s skin cancer drug Tafinlar

But only on condition the company cuts its price

- PMLiVE

Pharma is turning its attention to consumer healthcare

Pharma is no stranger to over-the-counter remedies but, as a number of recent deals show, consumer healthcare’s star is rising

- PMLiVE

Questions raised about affordability of asthma antibodies

Positive data on GSK and Teva anti-IL-5 candidates at ERS congress highlights cost concerns

Novartis building

Novartis’ Ultibro tops Seretide in comparative COPD trial

Will help Novartis position Ultibro as a corticosteroid-free alternative to GSK's blockbuster

- PMLiVE

GSK Ebola vaccine to start safety studies

Will use volunteers in the US, UK and Africa

- PMLiVE

ViiV bags US approval for HIV blockbuster-in-waiting

Drug combines antiretrovirals with Tivicay

- PMLiVE

Ex GSK exec to lead Sanford-Burnham

Perry Nisen appointed CEO at research institute

- PMLiVE

GSK relaunches COPD website

Revamped online hub offers tools and guidance for those affected by respiratory condition

- PMLiVE

GSK investigator jailed by Chinese authorities

Peter Humphrey found guilty of breaking privacy laws

dengue fever mosquito

GSK seeks approval for first malaria vaccine

Submits marketing application to European Medicines Agency

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links